Tissue converter and supplier of toilet rolls Accrol Group Holdings has issued another shocking update. We questioned previously how institutions got suckered into this one, they now appear to have…
Part 2 of our review of 2017 reflects on a mix of good, bad and downright ugly performances from stocks featured in our Blogs and research. We ask whether some…
News of the Temporary Suspension of Trading on AIM of tissue converter Accrol Group highlights yet again the perils of investing in a business where shareholders and private equity are…
Despite the distraction of the EU Referendum it was another encouraging month for new issues on AIM with 6 genuine new arrivals and a re-admission. The largest of the new arrivals…
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.